Johanna Van De Ven

Suggest Changes
Learn More
The aim of this study was to evaluate the tolerability of intratumoral administered recombinant human interleukin-12 (rhIL-12) in patients with head and neck squamous cell carcinoma. Six patients(More)
  • 1